Is there a need for other cardiovascular risk factors besides the established risk factors?
K. Tziomalos (97 – 101)
Pathophysiological mechanisms of dyslipidemia in patients with nephrotic syndrome: A fresh look
S. Filippas-Ntekouan, M.S. Elisaf (102 – 110)
PCSK9 Inhibitors: Research and new perspectives in clinical practice
E. Charatsi, I. Tsigeridis (111 – 119)
Familial hypercholesterolemia is undertreated in clinical practice
F. Barkas, E. Liberopoulos, G. Liamis, M. Elisaf 120 – 130
The “Hellenic Journal of Atherosclerosis” is a peer-reviewed academic journal which publishes all sources papers concerned with research and investigation on atherosclerosis, its complications, and related diseases, including: Lipoprotein metabolism, arterial and vascular biology and disease, thrombosis, inflammation, disorders of lipid transport diabetes and hypertension as related to atherosclerosis, and cardiovascular risk factors. The editors are also interested in clinical papers dealing with case studies of specific or general interest, new or unusual lipid syndromes, and the genetic basis and familial incidence of atherosclerosis and related diseases. High quality reports of controlled clinical trials of drugs or diets will be considered provided the paper deals with the mechanism of action of the drug or diet.